Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
25.47
+0.01 (0.04%)
At close: Dec 5, 2025, 4:00 PM EST
25.25
-0.22 (-0.86%)
After-hours: Dec 5, 2025, 5:48 PM EST
Lyell Immunopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -325.66 | -342.99 | -234.63 | -183.12 | -250.22 | -204.47 | |
| Depreciation & Amortization | 14.17 | 19.63 | 20.25 | 18.02 | 13.62 | 4.29 | |
| Loss (Gain) From Sale of Assets | 4.43 | 1.34 | 1.51 | 0.1 | 1.21 | -4.88 | |
| Asset Writedown & Restructuring Costs | 139.92 | 138.48 | - | - | - | - | |
| Loss (Gain) From Sale of Investments | -2.79 | -1.71 | 3.33 | 1.15 | 38.35 | 0.54 | |
| Stock-Based Compensation | 24.34 | 33.14 | 47.08 | 81.92 | 62.2 | 33.26 | |
| Other Operating Activities | -8.9 | -7.17 | -4.65 | -5.62 | 4.57 | 10.72 | |
| Change in Accounts Payable | -4.7 | -3.23 | 1.46 | 0.67 | 0.09 | -0.28 | |
| Change in Unearned Revenue | - | - | - | -84.65 | -10.51 | -7.76 | |
| Change in Other Net Operating Assets | -5.83 | 0.11 | 1.96 | 1.97 | 14.43 | 7.7 | |
| Operating Cash Flow | -165.02 | -162.39 | -163.69 | -169.56 | -126.25 | -160.87 | |
| Capital Expenditures | -0.52 | -0.46 | -2.69 | -24.28 | -65.5 | -51.48 | |
| Cash Acquisitions | -31.35 | -31.35 | - | - | - | - | |
| Investment in Securities | 170.57 | 154.23 | 186.73 | 12.74 | -56.07 | -222.04 | |
| Investing Cash Flow | 138.97 | 122.42 | 184.05 | -11.54 | -121.57 | -273.52 | |
| Issuance of Common Stock | 50.62 | 1.4 | 2.2 | 11.1 | 401.24 | 0.37 | |
| Repurchase of Common Stock | - | -0.08 | -0.46 | -0.46 | - | -11.81 | |
| Financing Cash Flow | 50.62 | 1.33 | 1.74 | 10.64 | 401.24 | 476.79 | |
| Net Cash Flow | 24.57 | -38.64 | 22.1 | -170.46 | 153.42 | 42.4 | |
| Free Cash Flow | -165.54 | -162.86 | -166.38 | -193.83 | -191.75 | -212.36 | |
| Free Cash Flow Margin | -403743.90% | -266980.33% | -127984.62% | -228.89% | -1800.50% | -2737.94% | |
| Free Cash Flow Per Share | -10.71 | -12.46 | -13.26 | -15.69 | -28.22 | -320.34 | |
| Levered Free Cash Flow | -79.68 | -67.56 | -90.36 | -53.9 | -129.82 | -128 | |
| Unlevered Free Cash Flow | -79.68 | -67.56 | -90.36 | -53.9 | -129.82 | -128 | |
| Change in Working Capital | -10.53 | -3.12 | 3.42 | -82.02 | 4.01 | -0.34 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.